AKBA vs CPB · rev $102.7M vs P/E 12, rev $10.25B
Akebia Ther (AKBA) versus Campbell’s Co (CPB) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
Campbell’s Co (CPB) is a packaged foods company listed on US.
Latest reported AKBA revenue for 2026-06-30 was $102.7M. Net income was -$18.0M. Revenue was up 91.8% from 2026-03-31 to 2026-06-30. AKBA currently screens at market cap $260.1M.
Latest reported CPB revenue for 2025-08-03 was $10.25B. Net income was $602.0M. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
AKBA currently screens at market cap $260.1M. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
Not investment advice. Open the AKBA and CPB stock pages for the full models.
Not investment advice.